Physician profile
Nathaniel Valin
NPI 1588646616
$40,262.95
in general payments reported to CMS, 2019-2025
52 companies · $2,030 in 2025
The $2,030 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,479 · 2020: $1,702 · 2021: $2,507 · 2022: $14K · 2023: $1,736 · 2024: $12K · 2025: $2,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,779 · Food and Beverage: $7,311 · Debt Forgiveness: $21.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,778.58 |
| Food and Beverage | $7,310.52 |
| Debt Forgiveness | $21.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $8,922.16 | 2019-2025 | Barostim Neo System |
| Medtronic, INC. | $8,763.76 | 2021-2025 | Micra, Onyx Frontier, Resolute Onyx |
| Penumbra, INC. | $4,943.26 | 2019-2025 | Indigo System, Ruby Coil |
| Cardiovascular Systems INC. | $4,469.84 | 2019-2023 | Diamondback Coronary |
| Abiomed | $3,804.91 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,479.61 | 2019-2025 | General - Balloon Catheters, Avvigo Guidance System, Watchman Flx |
| Janssen Pharmaceuticals, INC | $1,169.45 | 2019-2024 | Xarelto |
| Abbott Laboratories | $752.12 | 2020-2024 | Amplatzer Amulet, Amplatzer Talisman, Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $631.07 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $320.38 | 2019-2022 | |
| Shockwave Medical, INC | $317.67 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $300.57 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $298.93 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $275.75 | 2019-2025 | |
| Pfizer INC. | $263.62 | 2019-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $259.49 | 2019-2022 | |
| Amgen INC. | $258.60 | 2019-2022 | |
| Edwards Lifesciences Corporation | $247.67 | 2023-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $242.28 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $241.27 | 2022-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $204.01 | 2019-2025 | Farxiga, Andexxa |
| Medtronic Vascular, INC. | $199.66 | 2019-2020 | |
| Esperion Therapeutics, INC. | $169.08 | 2021-2022 | |
| Atricure, INC. | $165.51 | 2022-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System |
| Merck Sharp & Dohme LLC | $155.91 | 2021-2025 | Verquvo |
| Angiodynamics, INC. | $148.97 | 2022-2024 | Alphavac |
| Inari Medical, INC. | $148.44 | 2020-2022 | |
| Livanova USA, INC. | $113.35 | 2021-2023 | Protekduo |
| Cleerly, INC. | $101.76 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Actelion Pharmaceuticals US, INC. | $91.99 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Impulse Dynamics (USA) INC. | $77.19 | 2021-2024 | Optimizer, Optimizer |
| Novo Nordisk INC | $74.33 | 2021-2023 | Ozempic, Wegovy |
| Philips North America LLC | $60.12 | 2019-2024 | (Bs0) Mechanical Atherectomy |
| United Therapeutics Corporation | $57.71 | 2025 | Tyvaso |
| Kowa Pharmaceuticals America, INC. | $57.51 | 2020 | |
| Gilead Sciences, INC. | $56.07 | 2019 | |
| Irhythm Technologies, INC. | $50.15 | 2019-2022 | |
| Biotronik INC. | $47.05 | 2019 | |
| Alnylam Pharmaceuticals INC. | $41.89 | 2019-2025 | Amvuttra |
| Chiesi USA, INC. | $33.83 | 2022-2023 | Cleviprex, Kengreal |
| Arbor Pharmaceuticals, INC. | $33.58 | 2021 | |
| Acist Medical Systems, INC. | $26.07 | 2020 | |
| Bardy Diagnostics, INC. | $25.00 | 2019 | |
| Braemar Manufacturing, LLC | $24.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.51 | 2021 | |
| Terumo Medical Corporation | $22.21 | 2023 | Metacross Otw, Angio-Seal |
| Kiniksa Pharmaceuticals International, Plc | $21.91 | 2024 | Arcalyst |
| Zoll Circulation INC | $16.52 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.17 | 2023 | Evkeeza |
| Teleflex LLC | $14.66 | 2024 | Trapliner |
| W. L. Gore & Associates, INC. | $11.71 | 2021 | |
| Elutia, INC. | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Valin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.